Back

Half of implantable cardioverter-defibrillator patients remain at risk of painful shocks in the last moments of life

1 September 2024 (18:00 - 18:50)
Organised by: Logo
Congress Presentation Part of: Implantable cardioverter defibrillators: maximising protection and quality of life Implantable Cardioverter-Defibrillator (ICD) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Dilek Yilmaz

Leiden University Medical Center, Leiden (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Regional results of the lead evaluation for defibrillation and reliability (LEADR) trial
Doctor P. Mason (Charlottesville, US)
Abstract Slides Video
Presentation thumbnail
Routine chest X-ray post cardiac implantable electronic device implantation: is it really required? Experience from a tertiary centre
Ms J. Tan (London, GB)
Abstract Slides Video
Presentation thumbnail
Assessment of quality of life and ICD shock-related anxiety in Asian patients with implantable cardioverter defibrillator in the PainFree SST study
Associate Professor Y. Kondo (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Atrial rates during treated ventricular tachycardia in patients with implantable cardioverter defibrillators: clinical implications of a vagal sinus node response
Miss R. Martin (London, GB)
Abstract Slides Video
Presentation thumbnail
All-cause mortality and incidence of appropriate therapy from a primary preventive implantable cardioverter defibrillator in patients with non-ischemic dilated cardiomyopathy
Doctor T. Nguyen (Oslo, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Implantable cardioverter defibrillators: maximising protection and quality of life

The Event

Event poster

ESC Congress 2024

1 September 2024 18:00 CET
You may be interested in
thumbnail
Congress Presentation
Defibrillation deactivation state and activation status in patients with implantable cardioverter-defibrillators at the end of life
thumbnail
Congress Presentation
A systematic review of Australian hospitals' policies on the deactivation of implantable cardioverter defibrillators
thumbnail
Congress Session
Recent advances in implantable cardioverter defibrillator therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources